Literature DB >> 29221689

Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response.

Kai Qi1, Na Li2, Zhenyu Zhang3, Gerry Melino4.   

Abstract

Mesenchymal stem cells (MSCs) exist in almost all tissues with the capability to differentiate into several different cell types and hold great promise in tissue repairs in a cell replacement manner. The study of the bidirectional regulation between MSCs and immune response has ushered an age of rethinking of tissue regeneration in the process of stem cell-based tissue repairs. By sensing damaged signals, both endogenous and exogenous MSCs migrate to the damaged site where they involve in the reconstitution of the immune microenvironment and empower tissue stem/progenitor cells and other resident cells, whereby facilitate tissue repairs. This MSC-based therapeutic manner is conferred as cell empowerment. In this process, MSCs have been found to exert extensive immunosuppression on both innate and adaptive immune response, while such regulation needs to be licensed by inflammation. More importantly, the immunoregulation of MSCs is highly plastic, especially in the context of pathological microenvironment. Understanding the immunoregulatory properties of MSCs is necessary for appropriate application of MSCs. Here we review the current studies on the crosstalk of MSCs and immune response in disease pathogenesis and therapy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immune responses; Mesenchymal stem cells

Mesh:

Year:  2017        PMID: 29221689     DOI: 10.1016/j.cellimm.2017.11.010

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  26 in total

Review 1.  Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents.

Authors:  Zahra Abbasi-Malati; Amaneh Mohammadi Roushandeh; Yoshikazu Kuwahara; Mehryar Habibi Roudkenar
Journal:  Stem Cell Rev Rep       Date:  2018-08       Impact factor: 5.739

2.  Substances for regenerative wound healing during antler renewal stimulated scar-less restoration of rat cutaneous wounds.

Authors:  Qianqian Guo; Zhen Liu; Junjun Zheng; Haiping Zhao; Chunyi Li
Journal:  Cell Tissue Res       Date:  2021-08-14       Impact factor: 5.249

Review 3.  Mesenchymal stromal cells: promising treatment for liver cirrhosis.

Authors:  Lichao Yao; Xue Hu; Kai Dai; Mengqin Yuan; Pingji Liu; Qiuling Zhang; Yingan Jiang
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

Review 4.  Research update of adipose tissue-based therapies in regenerative dermatology.

Authors:  Barbara Bellei; Emilia Migliano; Mauro Picardo
Journal:  Stem Cell Rev Rep       Date:  2022-03-01       Impact factor: 6.692

5.  Exosomes with high level of miR-181c from bone marrow-derived mesenchymal stem cells inhibit inflammation and apoptosis to alleviate spinal cord injury.

Authors:  Meng Zhang; Lin Wang; Sihua Huang; Xijing He
Journal:  J Mol Histol       Date:  2021-02-06       Impact factor: 2.611

Review 6.  Engineering of Immune Microenvironment for Enhanced Tissue Remodeling.

Authors:  Ga Ryang Ko; Jung Seung Lee
Journal:  Tissue Eng Regen Med       Date:  2022-01-18       Impact factor: 4.169

Review 7.  Hair follicle stem cells as a skin-organizing signaling center during adult homeostasis.

Authors:  Kefei Nina Li; Tudorita Tumbar
Journal:  EMBO J       Date:  2021-04-20       Impact factor: 14.012

8.  Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2.

Authors:  Handan Sevim; Yusuf Çetin Kocaefe; Mehmet Ali Onur; Duygu Uçkan-Çetinkaya; Özer Aylin Gürpınar
Journal:  Stem Cell Res Ther       Date:  2018-07-18       Impact factor: 6.832

9.  Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics.

Authors:  Le Wang; Leisheng Zhang; Xue Liang; Jiaqi Zou; Na Liu; Tengli Liu; Guanqiao Wang; Xuejie Ding; Yaojuan Liu; Boya Zhang; Rui Liang; Shusen Wang
Journal:  Int J Stem Cells       Date:  2020-07-30       Impact factor: 2.500

10.  Controlled aggregation enhances immunomodulatory potential of mesenchymal stromal cell aggregates.

Authors:  Angela W Xie; Nicholas A Zacharias; Bernard Y K Binder; William L Murphy
Journal:  Stem Cells Transl Med       Date:  2021-04-05       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.